1 minute read
Mar. 12, 2022

Molecules of the Month - February 2022

GCC5694A

oral SGLT2 inhibitor Clinical candidate for diabetes from literature SGLT2 inhibitor Bioorganic Med. Chem. Lett. GC Pharma (Green Cross)

twitterlinkedinprintemail